Cbeyond (CBEY) Posts Prelim. Q4 Sales; Guides FY12 Below the Street
Tweet
Share
E-mailGet Alerts CBEY Hot Sheet
Price: $9.99 --0%
Financial Fact:
(Loss) income before income taxes: -9.9M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
(Loss) income before income taxes: -9.9M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Cbeyond (Nasdaq: CBEY) reports preliminary Q4 sales of $123 million, which compares to the Street estimate of $123.42 million.
Sees Fy12 sales of $485-$490 million, vs. the consensus estimate of $509.7 million.
Sees Fy12 sales of $485-$490 million, vs. the consensus estimate of $509.7 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- J. M. Smucker (SJM) Tops Q1 EPS by 103c
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
